Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence of a new SARS-CoV-2 variant in the UK
Julian W. Tang, Paul Anantharajah Tambyah, David S.C. Hui
Journal of Infection (2020) Vol. 82, Iss. 4, pp. e27-e28
Open Access | Times Cited: 287

Showing 1-25 of 287 citing articles:

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen, Daniela Michlmayr, Sophie Gubbels, et al.
The Lancet (2021) Vol. 397, Iss. 10280, pp. 1204-1212
Open Access | Times Cited: 642
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li, Jianhui Nie, Jiajing Wu, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2362-2371.e9
Open Access | Times Cited: 381
Emergence of a Novel SARS-CoV-2 Variant in Southern California
Wenjuan Zhang, Brian Davis, Stephanie S. Chen, et al.
JAMA (2021) Vol. 325, Iss. 13, pp. 1324-1324
Open Access | Times Cited: 372
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 305
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
Rui Wang, Jiahui Chen, Kaifu Gao, et al.
Genomics (2021) Vol. 113, Iss. 4, pp. 2158-2170
Open Access | Times Cited: 197
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Lianlian Bian, Fan Gao, Jialu Zhang, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 365-373
Open Access | Times Cited: 168
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK
Julian W. Tang, Oliver T. R. Toovey, Kirsty N. Harvey, et al.
Journal of Infection (2021) Vol. 82, Iss. 4, pp. e8-e10
Open Access | Times Cited: 167
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 167
SERS Based Lateral Flow Immunoassay for Point-of-Care Detection of SARS-CoV-2 in Clinical Samples
Shalu Yadav, Mohd. Abubakar Sadique, Pushpesh Ranjan, et al.
ACS Applied Bio Materials (2021) Vol. 4, Iss. 4, pp. 2974-2995
Closed Access | Times Cited: 149
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 134
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Angel Yun-Kuan Thye, Jodi Woan‐Fei Law, Priyia Pusparajah, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1303-1303
Open Access | Times Cited: 120
Mutation Rates and Selection on Synonymous Mutations in SARS-CoV-2
Nicola De Maio, Conor R. Walker, Yatish Turakhia, et al.
Genome Biology and Evolution (2021) Vol. 13, Iss. 5
Open Access | Times Cited: 117
Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel
Itay Bar-Or, Merav Weil, Victoria Indenbaum, et al.
The Science of The Total Environment (2021) Vol. 789, pp. 148002-148002
Open Access | Times Cited: 104
Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
Charles M. King, Jonathan Sprent
Trends in Immunology (2021) Vol. 42, Iss. 4, pp. 312-322
Open Access | Times Cited: 99
Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis
Shi Zhao, Jingzhi Lou, Lirong Cao, et al.
Journal of Travel Medicine (2021) Vol. 28, Iss. 2
Open Access | Times Cited: 87
Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load
Frederik Plesner Lyngse, Kåre Mølbak, Robert Skov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 86
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4401-4413.e10
Open Access | Times Cited: 78
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
Seonghan Kim, Yi Liu, Zewei Lei, et al.
Journal of Chemical Theory and Computation (2021) Vol. 17, Iss. 12, pp. 7972-7979
Open Access | Times Cited: 76
Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK
Oliver T. R. Toovey, Kirsty N. Harvey, Paul Bird, et al.
Journal of Infection (2021) Vol. 82, Iss. 5, pp. e23-e24
Open Access | Times Cited: 74
The ventilation of buildings and other mitigating measures for COVID-19: a focus on wintertime
Henry C. Burridge, Rajesh K. Bhagat, Marc Stettler, et al.
Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences (2021) Vol. 477, Iss. 2247
Open Access | Times Cited: 74
The global transmission of new coronavirus variants
Yingjie Zhao, Jianping Huang, Li Zhang, et al.
Environmental Research (2021) Vol. 206, pp. 112240-112240
Open Access | Times Cited: 68
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
Gabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.
Cell Reports (2021) Vol. 37, Iss. 5, pp. 109928-109928
Open Access | Times Cited: 67
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Wenqiang Sun, Lihong He, He Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 65
Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics
Yuan Zhou, Li Zhang, Youhua Xie, et al.
Laboratory Investigation (2021) Vol. 102, Iss. 1, pp. 4-13
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top